[go: up one dir, main page]

NO20005128L - Sammensetning som innbefatter L-karnitin eller et alkanoyl-L- karnitin og NADH og/eller NADPH - Google Patents

Sammensetning som innbefatter L-karnitin eller et alkanoyl-L- karnitin og NADH og/eller NADPH

Info

Publication number
NO20005128L
NO20005128L NO20005128A NO20005128A NO20005128L NO 20005128 L NO20005128 L NO 20005128L NO 20005128 A NO20005128 A NO 20005128A NO 20005128 A NO20005128 A NO 20005128A NO 20005128 L NO20005128 L NO 20005128L
Authority
NO
Norway
Prior art keywords
carnitine
nadh
nadph
alkanoyl
composition
Prior art date
Application number
NO20005128A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005128D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20005128D0 publication Critical patent/NO20005128D0/no
Publication of NO20005128L publication Critical patent/NO20005128L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20005128A 1998-04-17 2000-10-12 Sammensetning som innbefatter L-karnitin eller et alkanoyl-L- karnitin og NADH og/eller NADPH NO20005128L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (2)

Publication Number Publication Date
NO20005128D0 NO20005128D0 (no) 2000-10-12
NO20005128L true NO20005128L (no) 2000-12-18

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005128A NO20005128L (no) 1998-04-17 2000-10-12 Sammensetning som innbefatter L-karnitin eller et alkanoyl-L- karnitin og NADH og/eller NADPH

Country Status (17)

Country Link
EP (1) EP1071424A1 (it)
JP (1) JP2002512191A (it)
KR (1) KR20010042765A (it)
CN (1) CN1299283A (it)
AU (1) AU750645B2 (it)
BR (1) BR9909712A (it)
CA (1) CA2328331A1 (it)
EE (1) EE200000601A (it)
HU (1) HUP0101914A3 (it)
IL (1) IL139014A0 (it)
IS (1) IS5663A (it)
IT (1) IT1299161B1 (it)
NO (1) NO20005128L (it)
PL (1) PL343482A1 (it)
SK (1) SK15442000A3 (it)
TR (1) TR200002894T2 (it)
WO (1) WO1999053921A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
JP2009532509A (ja) * 2007-05-11 2009-09-10 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 美容活性成分の送達に有用なゲル
US20120214870A1 (en) * 2009-08-31 2012-08-23 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
CN104840479A (zh) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
US10894059B2 (en) * 2017-12-22 2021-01-19 Bontac Bio-Engineering (Shenzhen) Co., Ltd NADH compound composition, and preparation and use thereof
WO2019200491A1 (de) 2018-04-20 2019-10-24 Pacotrade Ag Vorrichtung zum zerkleinern von in blockform bereitgestellten tiefgefrorenen lebensmitteln
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
EP3864969A4 (en) * 2018-10-10 2022-06-15 Leung, So Ngor Sally MEDICINAL COMPOSITION FOR SUPPLEMENTING DEFICIENCIES, PROCESS FOR THEIR PREPARATION AND ITS APPLICATION
CN117958433A (zh) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 不含咖啡因的抗疲劳功能组合物、饮料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (it) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Also Published As

Publication number Publication date
KR20010042765A (ko) 2001-05-25
PL343482A1 (en) 2001-08-27
IT1299161B1 (it) 2000-02-29
CA2328331A1 (en) 1999-10-28
JP2002512191A (ja) 2002-04-23
SK15442000A3 (sk) 2001-06-11
EP1071424A1 (en) 2001-01-31
AU750645B2 (en) 2002-07-25
IL139014A0 (en) 2001-11-25
TR200002894T2 (tr) 2001-01-22
BR9909712A (pt) 2000-12-26
IS5663A (is) 2000-10-13
NO20005128D0 (no) 2000-10-12
ITRM980238A1 (it) 1999-10-17
HUP0101914A3 (en) 2002-12-28
EE200000601A (et) 2002-04-15
WO1999053921A1 (en) 1999-10-28
AU3442899A (en) 1999-11-08
ITRM980238A0 (it) 1998-04-17
CN1299283A (zh) 2001-06-13
HUP0101914A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
NO995784D0 (no) Fytosterol og/eller fytosterolderivater
NO996491L (no) 4-brom- eller 4-iod-fenylaminobenzhydroksamsyre-derivater og deres anvendelse som MEK-inhibitorer
NO985039D0 (no) Alkyl-4-silyl-fenoler og estere derav som antiatherosklerotiske midler
DK1032575T3 (da) 2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor
DK1112005T4 (da) Antioxiderende præparat, som omfatter acetyl-L-carnitin og alfa-lipoinsyre
DK1112003T3 (da) Ny sammensætning og anvendelse
DK0857087T3 (da) Coating-sammensætning med antimikrobiel virkning i dåse og som tør film
NO20006488D0 (no) Sammensetning og anvendelse
NO20005191D0 (no) Glass-keramiske belegg og tettingsarrangementer, og disses bruk i bremseceller
DK1375503T3 (da) Dioxinoderivater og deres anvendelse som dopaminagonister
NO20005128L (no) Sammensetning som innbefatter L-karnitin eller et alkanoyl-L- karnitin og NADH og/eller NADPH
DE69926046D1 (de) Drucklager
DK1012137T3 (da) Aromatiske C-16-C-20-substituerede tetrahydro-prostaglandiner og deres anvendelse som prostaglandin FP-agonister
NO993467D0 (no) Granuler som innbefatter klavulanat og en eller flere eksipienter
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
NO994510L (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
NO995513D0 (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-A agonister
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
DE69937060D1 (de) Immunogene zusammensetzungen und deren verwendungen
NO986034D0 (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse
NO990440D0 (no) Preparat som innbefatter mupirocin og klorheksidin
NO20012973D0 (no) Polyester-polyuretanlim og anvendelsen derav
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20004904L (no) C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter
NO20006626D0 (no) Beleggingsmiddel og anvendelse herav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application